Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)
China
· Delayed Price · Currency is CNY 15.01
+0.10 (0.67%)
At close: Mar 10, 2026
SHE:300705 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,367 | 8,907 | 11,469 | 8,333 | 8,247 | 6,289 | Upgrade
|
| Market Cap Growth | -8.86% | -22.34% | 37.63% | 1.05% | 31.12% | 118.06% | Upgrade
|
| Enterprise Value | 7,203 | 8,564 | 11,228 | 8,362 | 8,274 | 6,265 | Upgrade
|
| Last Close Price | 14.91 | 17.60 | 23.06 | 16.70 | 17.06 | 13.00 | Upgrade
|
| PE Ratio | 16.27 | 17.38 | 31.14 | 30.90 | 40.38 | 76.46 | Upgrade
|
| Forward PE | 12.17 | 14.62 | 26.14 | 21.80 | 31.87 | - | Upgrade
|
| PS Ratio | 2.41 | 3.04 | 4.26 | 3.58 | 5.07 | 6.43 | Upgrade
|
| PB Ratio | 2.73 | 3.53 | 5.81 | 5.37 | 7.50 | 7.53 | Upgrade
|
| P/TBV Ratio | 2.89 | 3.69 | 6.09 | 5.70 | 8.07 | 8.02 | Upgrade
|
| P/FCF Ratio | 58.86 | 25.56 | 2626.25 | - | 126.98 | 87.79 | Upgrade
|
| P/OCF Ratio | 12.28 | 11.93 | 26.60 | 30.98 | 43.21 | 41.93 | Upgrade
|
| EV/Sales Ratio | 2.36 | 2.92 | 4.17 | 3.60 | 5.08 | 6.41 | Upgrade
|
| EV/EBITDA Ratio | 12.02 | 13.51 | 25.15 | 24.70 | 31.25 | 49.57 | Upgrade
|
| EV/EBIT Ratio | 14.66 | 15.81 | 29.93 | 29.99 | 39.17 | 80.17 | Upgrade
|
| EV/FCF Ratio | 57.55 | 24.57 | 2570.94 | - | 127.41 | 87.45 | Upgrade
|
| Debt / Equity Ratio | 0.18 | 0.12 | 0.20 | 0.20 | 0.30 | 0.11 | Upgrade
|
| Debt / EBITDA Ratio | 0.82 | 0.48 | 0.87 | 0.93 | 1.24 | 0.70 | Upgrade
|
| Debt / FCF Ratio | 3.92 | 0.87 | 89.40 | - | 5.06 | 1.23 | Upgrade
|
| Net Debt / Equity Ratio | -0.07 | -0.16 | -0.06 | -0.08 | -0.15 | -0.06 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.31 | -0.63 | -0.28 | -0.35 | -0.64 | -0.37 | Upgrade
|
| Net Debt / FCF Ratio | -1.47 | -1.15 | -28.60 | 0.83 | -2.62 | -0.65 | Upgrade
|
| Asset Turnover | 0.88 | 0.94 | 1.04 | 1.15 | 1.13 | 0.89 | Upgrade
|
| Inventory Turnover | 2.21 | 2.50 | 2.46 | 2.29 | 1.99 | 1.75 | Upgrade
|
| Quick Ratio | 3.40 | 3.01 | 2.76 | 2.12 | 2.12 | 1.80 | Upgrade
|
| Current Ratio | 4.81 | 4.09 | 3.44 | 2.72 | 2.76 | 2.78 | Upgrade
|
| Return on Equity (ROE) | 18.47% | 22.77% | 20.89% | 20.34% | 21.11% | 10.30% | Upgrade
|
| Return on Assets (ROA) | 8.89% | 10.84% | 9.07% | 8.62% | 9.18% | 4.44% | Upgrade
|
| Return on Invested Capital (ROIC) | 18.21% | 24.41% | 20.94% | 21.94% | 22.20% | 9.08% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.70% | 18.20% | 15.30% | 15.00% | 15.40% | 8.20% | Upgrade
|
| Earnings Yield | 6.37% | 5.75% | 3.21% | 3.24% | 2.48% | 1.31% | Upgrade
|
| FCF Yield | 1.70% | 3.91% | 0.04% | -1.73% | 0.79% | 1.14% | Upgrade
|
| Dividend Yield | 2.10% | 1.78% | 0.99% | 1.01% | 0.78% | 0.17% | Upgrade
|
| Payout Ratio | 34.28% | 22.58% | 25.69% | 25.70% | 7.35% | 16.74% | Upgrade
|
| Buyback Yield / Dilution | -0.79% | 2.34% | -9.55% | 0.15% | -0.13% | 1.89% | Upgrade
|
| Total Shareholder Return | 1.30% | 4.12% | -8.56% | 1.16% | 0.66% | 2.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.